A test with high predictive value would accurately confirm disease presence if positive and exclude it if negative, circumventing risky and expensive laparoscopic surgery.
Spotlighting newly approved medications that treat breast cancer, colorectal cancer, NTRK-positive solid tumors, and nasopharyngeal cancer.